Georgian athlete Gvantsa Gulordava receives 3-year ban for anti-doping rule violation
Para powerlifter returned an adverse analytical finding for a Prohibited Substance at the Cairo 2025 Para Powerlifting Elite World Championships. 24 Mar 2026
The International Paralympic Committee (IPC) has banned Para powerlifting athlete Gvantsa Gulordava for a period of three (3) years for committing an anti-doping rule violation (ADRV), in breach of the IPC Anti-Doping Code (the Code).
The Georgian athlete returned an adverse analytical finding (AAF) for a Prohibited Substance in a urine sample provided in-competition on 13 October 2025 during the Women’s up to 73 kg competition at the Cairo 2025 Para Powerlifting Elite World Championships.
The prohibited substance was a metabolite of drostanolone. Drostanolone is included on the World Anti-Doping Agency (WADA) 2025 Prohibited List under the class S1.1 Anabolic Androgenic Steroids (AAS). It is as a non-Specified Substance, for the purposes of the Code.
The athlete was provisionally suspended by the IPC on 16 January 2026 pending a resolution of her case. The IPC subsequently charged the athlete with an ADRV under Part Three of the Code (the IPC IF Rules).
The athlete admitted her commission of the ADRV, and accepted the full consequences proposed by the IPC. As a result of her violation, the athlete will be ineligible for competition and other sporting activities (other than authorised anti-doping education or rehabilitation programs) for three (3) years from 16 January 2026 until 15 January 2029.
All the results obtained by the athlete at the Cairo 2025 Para Powerlifting Elite World Championships (including in the Women’s up to 73 kg competition) are disqualified, with all resulting Consequences, including forfeiture of any medals, points and prizes. All other results obtained by the athlete from the date the Sample was collected until the commencement of the Provisional Suspension are also disqualified, with all resulting Consequences, including forfeiture of any medals, points and prizes.
Each athlete is strictly liable for the substances found in their sample. An ADRV occurs whenever a prohibited substance (or its metabolites or markers) is found in their bodily sample, whether or not the athlete intentionally or unintentionally used a prohibited substance or was negligent or otherwise at fault.
As a signatory of the World Anti-Doping Code (the WADC), the IPC remains committed to a doping-free sporting environment at all levels. The IPC has established the IPC Anti-Doping Code in compliance with the general principles of the WADC, including the WADC International Standards, expecting that, in the spirit of sport, it will lead the fight against doping in sport for athletes with an impairment.
